Silvia Ricci (S Ricci)

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 15

Top Topics

Antimicrobial Resistance

Respiratory Syncytial Virus

Top Venues

Expert review of vaccines

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Ricci, Chiara Azzari, Emanuele Amodio, Paolo Castiglia
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion. Expert review of vaccines 22 (1) (2023)
Silvia Ricci, Chiara Azzari, Emanuele Amodio, Paolo Castiglia
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion. Expert review of vaccines 22 (1) (2023)
Silvia Ricci, Chiara Azzari, Emanuele Amodio, Paolo Castiglia
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion. Expert review of vaccines (2023)
Federica Barbati, Edoardo Marrani, Beatrice Volpi, Giovanna Ferrara, Lorenzo Lodi, Maria Vincenza Mastrolia, Clementina Canessa, Ilaria Maccora, Gabriele Simonini, Chiara Azzari, Silvia Ricci
Mycophenolate mofetil-induced hypogammaglobulinemia and infectious disease susceptibility in pediatric patients with chronic rheumatic disorders: a monocentric retrospective study. European journal of pediatrics 181 (9) (2022)
Silvia Ricci, Francesca Perugia, Barbara Piccini, Lorenzo Lodi, Francesco Pegoraro, Mattia Giovannini, Giovanni Rombolà, Giancarlo Perferi, Sonia Toni, Chiara Azzari
DR4/DQ2 haplotype confers susceptibility to T1DM with early clinical disease onset: A retrospective analysis in a tertiary-care hospital in Italy. PloS one 17 (11) (2022)
Silvia Ricci, Francesca Lippi, Clementina Canessa, Chiara Guarnieri, Roberta Macchia, Chiara Azzari
Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency. International journal of immunopathology and pharmacology 34 (2021)
Chiara Azzari, Maria Moriondo, Francesco Nieddu, Valentina Guarnieri, Lorenzo Lodi, Clementina Canessa, Giuseppe Indolfi, Mattia Giovannini, Giuseppina Napoletano, Francesca Russo, Tatjana Baldovin, Silvia Cocchio, Silvia Ricci, Vincenzo Baldo
Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014-2018). Vaccines 8 (3) (2020)
Lorenzo Lodi, Chiara Rubino, Silvia Ricci, Giuseppe Indolfi, Mattia Giovannini, Guglielmo Consales, Simone Magazzini, Franco Lai, Pierluigi Vasarri, Antonella Conti, Tamara Brunelli, Maria Moriondo, Chiara Azzari
Neisseria meningitidis with H552Y substitution on rpoB gene shows attenuated behavior in vivo: report of a rifampicin-resistant case following chemoprophylaxis. Journal of chemotherapy (Florence, Italy) 32 (2) (2020)
Mattia Giovannini, Lorenzo Lodi, Silvia Ricci
T-cell immunomodulation by bile acid metabolites. Allergy 75 (7) (2020)
Federica Barbati, Maria Moriondo, Laura Pisano, Elisa Calistri, Lorenzo Lodi, Silvia Ricci, Mattia Giovannini, Clementina Canessa, Giuseppe Indolfi, Chiara Azzari
Epidemiology of Respiratory Syncytial Virus-Related Hospitalization Over a 5-Year Period in Italy: Evaluation of Seasonality and Age Distribution Before Vaccine Introduction. Vaccines 8 (1) (2020)
Antonio Pecoraro, Silvia Ricci, Alessandra Vultaggio, Giorgio Maria Boggia, Giuseppe Spadaro, null null
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies. Clinical drug investigation 40 (3) (2020)
Sara Guiducci, Maria Moriondo, Francesco Nieddu, Silvia Ricci, Elisa De Vitis, Arianna Casini, Giovanni Maria Poggi, Giuseppe Indolfi, Massimo Resti, Chiara Azzari
Culture and Real-time Polymerase Chain reaction sensitivity in the diagnosis of invasive meningococcal disease: Does culture miss less severe cases? PloS one 14 (3) (2019)
Lorenzo Lodi, Silvia Ricci, Francesco Nieddu, Maria Moriondo, Francesca Lippi, Clementina Canessa, Giusi Mangone, Martina Cortimiglia, Arianna Casini, Ersilia Lucenteforte, Giuseppe Indolfi, Massimo Resti, Chiara Azzari
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children. Vaccines 7 (4) (2019)
Silvia Ricci, A Montemaggi, F Nieddu, D Serranti, G Indolfi, M Moriondo, C Azzari
Is primary meningococcal arthritis in children more frequent than we expect? Two pediatric case reports revealed by molecular test. BMC infectious diseases 18 (1) (2018)
Silvia Ricci, Francesca Romano, Francesco Nieddu, Capucine Picard, Chiara Azzari
OL-EDA-ID Syndrome: a Novel Hypomorphic NEMO Mutation Associated with a Severe Clinical Presentation and Transient HLH. Journal of clinical immunology 37 (1) (2016)